{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:02:30Z","timestamp":1790650950010,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The pathogenesis of atopic dermatitis (AD) involves various mediators, including cytokines and chemokines, which are produced by immune cells, such as dendritic cells and lymphocytes, and non-immune cells, such as epidermal cells. Several mediators, including thymus and activation-regulated chemokine (TARC), are used as biomarkers for AD severity and activity. However, additional local and systemic biomarkers of AD are required.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study will include 10 male patients with AD and 5 healthy adult males (age range: 20\u201380 years). The Eczema Area and Severity Index will be used to objectively evaluate the clinical findings. In addition, the severity of eruptions will be assessed on a 5-point scale by scoring symptoms (erythema, edema\/papules, oozing\/crusting, excoriation, lichenification, and xerosis), and the total intensity will be calculated by adding the symptom scores together. Subjective symptoms will be assessed using a peak pruritus numerical rating scale. Laboratory tests, including measurements of peripheral eosinophil count and serum total immunoglobulin E, TARC, and lactate dehydrogenase levels, will be performed. Using blood samples and extracts of stratum corneum samples obtained by tape stripping, we will conduct an exploratory analysis of protein expression using an antibody array to identify mediators whose levels are significantly altered in patients with AD. After 4 to 8 weeks, blood samples and stratum corneum samples will be collected again from AD patients. Moreover, we will examine whether the candidate proteins can be quantified using enzyme-linked immunosorbent assays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>This is an important study exploring potential local and systemic biomarkers of AD. The results of this study will be clinically meaningful for the discovery of new biomarkers for diagnosing and assessing the severity of AD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000031267","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T19:10:51Z","timestamp":1666638651000},"page":"e31267","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Exploratory analyses of biomarkers in blood and stratum corneum in patients with atopic dermatitis"],"prefix":"10.1097","volume":"101","author":[{"given":"Ayano","family":"Maruyama","sequence":"first","affiliation":[{"name":"Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9379-9584","authenticated-orcid":false,"given":"Risa","family":"Tamagawa-Mineoka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Nishigaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Katoh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"356","article-title":"Committee for clinical practice guidelines for the management of atopic dermatitis 2018, the Japanese society of allergology, the Japanese dermatology association.","volume":"69","author":"Katoh","year":"2020","journal-title":"Japanese Guidelines Atopic Dermatitis 2020 Allergol Int"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.alit.2016.12.002","article-title":"Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.","volume":"66","author":"Furue","year":"2017","journal-title":"Allergol Int"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/ijms21082671","article-title":"Atopic dermatitis: identification and management of complicating factors.","volume":"21","author":"Tamagawa-Mineoka","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2016.05.002","article-title":"Atopic dermatitis and filaggrin.","volume":"42","author":"Cabanillas","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/all.12369","article-title":"Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations.","volume":"69","author":"Kono","year":"2014","journal-title":"Allergy"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.alit.2020.02.001","article-title":"Stratum corneum interleukin-25 expressions correlate with the degree of dry skin and acute lesions in atopic dermatitis.","volume":"69","author":"Nakamura","year":"2020","journal-title":"Allergol Int"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2019.02.006","article-title":"Stratum corneum interleukin-33 expressions correlate with the degree of lichenification and pruritus in atopic dermatitis lesions.","volume":"201","author":"Nakamura","year":"2019","journal-title":"Clin Immunol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cei.12021","article-title":"Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis.","volume":"171","author":"Sano","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/jid.2008.111","article-title":"Possible pathogenic role of Th17 cells for atopic dermatitis.","volume":"128","author":"Koga","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","article-title":"Biomarkers in atopic dermatitis-a review on behalf of the international Eczema council.","volume":"147","author":"Renert-Yuval","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/ped.2016.0703","article-title":"Biomarkers for atopic dermatitis in children.","volume":"29","author":"Tamagawa-Mineoka","year":"2016","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jid.2016.09.037","article-title":"An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease.","volume":"137","author":"Ungar","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2020.08.041","article-title":"Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.","volume":"147","author":"He","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mai.2001.113237","article-title":"Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity.","volume":"107","author":"Kakinuma","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1398-9995.2010.02361.x","article-title":"Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis.","volume":"65","author":"Morita","year":"2010","journal-title":"Allergy"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2011.05.042","article-title":"Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.","volume":"128","author":"Tintle","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2249.2002.01727.x","article-title":"Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.","volume":"127","author":"Kakinuma","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.","volume":"123","author":"Nograles","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jdermsci.2019.05.005","article-title":"Stratum corneum toll-like receptor 3 expressions correlate with the severity of atopic dermatitis lesions.","volume":"94","author":"Nakamura","year":"2019","journal-title":"J Dermatol Sci"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.17744","article-title":"Peak pruritus numerical rating scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.","volume":"181","author":"Yosipovitch","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:41:52Z","timestamp":1746333712000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":21,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031267","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}